Release of interleukin-10 and neurotrophic factors in the choroid plexus: possible inductors of neurogenesis following copolymer-1 immunization after cerebral ischemia

Copolymer-1 (Cop-1) is a peptide with immunomodulatory properties, approved by the Food and Drug Administration of United States in the treatment of multiple sclerosis. Cop-1 has been shown to exert neuroprotective effects and induce neurogenesis in cerebral ischemia models. Nevertheless, the mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz, Yolanda, García, Edna E., Gálvez, Jessica V., Arias-Santiago, Stella V., Carvajal, Horacio G., Silva-García, Raúl, Bonilla-Jaime, Herlinda, Rojas-Castañeda, Julio, Ibarra, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128049/
https://www.ncbi.nlm.nih.gov/pubmed/30136689
http://dx.doi.org/10.4103/1673-5374.238615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128049/
https://www.ncbi.nlm.nih.gov/pubmed/30136689
http://dx.doi.org/10.4103/1673-5374.238615

Ejemplares similares